Search

The magnitude and pattern of the hematocrit (Hct), hemoglobin (Hb), and plasma volume (PV) responses during and upon recovery from two resistance training protocols based on either a ten-repetition maximum (10 RM) or five-repetition maximum (5 RM) resistance was examined. Twelve college-aged male resistance exercise trainers were equally divided between the protocols and performed at least four workouts prior to testing to determine the 10 RM or 5 RM for each exercise set. Each protocol included three sets of nine exercises. The 10-RM session used one-minute rest periods between sets, and two minutes between exercises. The 5-RM session employed three-minute rest periods between sets and exercises. A catheter inserted in the forearm allowed for venous blood sampling after twenty minutes supine rest, the last set of each exercise, and at fifteen and thirty minutes of recovery. Control conditions were included for posture (P) and limb motion (U). Loaded exercise (L) was significantly different from U and P controls for Hct, Hb, and PV responses. For 10 RM and 5 RM respectively, the mean change from rest was 6.2 (+/- 0.9) and 3.5 (+/- 0.4) % for Hct, 2.2 (+/- 0.2) and 1.2 (+/- 0.1) gm . dl (-1) for Hb, and - 22.6 (+/- 2.3) and - 13.0 (+/- 1.2) % for PV. The main effect for protocol was significant for Hct (p = 0.0006) and Hb (p = 0.0033), with 10-RM changes being greater than 5 RM. The greatest increase in Hct and Hb occurred after the first set for both protocols. An increase in Hct and Hb during the protocol was observed for the 10 RM, but not the 5 RM. During recovery, Hct and Hb were elevated above rest for 10 RM, but not 5 RM. PV decreases mirrored Hct and Hb in pattern of change and significance. The data demonstrate that magnitude and pattern of Hct, Hb, and PV was dependent on the type of resistance training protocol.

The purpose of this study was to evaluate the effect of the beta 2-agonist albuterol (salbutamol) at twice the normal dosage (360 micrograms) on power output during a 30-second Wingate test and pulmonary function in highly trained cyclists (4 category 1 and 10 category II U.S.C.F. track cyclists). The cyclists did not have a history of exercise induced bronchial spasms, and a 5 step methacholine challenge confirmed all subjects to be non-asthmatic. The project was performed in a random block, double blind design. Twenty minutes before the 30-second Wingate cycle ergometer exercise, albuterol (90 micrograms per dose) or a saline placebo was administered by inhaler in 4 metered doses. Pulmonary function tests were performed at rest, 20 minutes post-inhalation, and 5, 10, 15 minutes post-exercise. After a standard warm-up, a 30-second Wingate anaerobic power test was performed on a cycle ergometer at a resistance of 0.10 kg (kg body mass)-1. Multi-variate ANOVA revealed no significant difference between the albuterol and placebo treatment for the anaerobic power measures: peak power (1,136.7 +/- 40.9 vs 1,124.8 +/- 39.8 W, mean +/- s.e.), total work (27,213.6 +/- 653.1 vs 27,093.3 +/- 677.4j), time to peak power (4.5 +/- 0.2 vs 4.8 +/- 0.5 s), and fatigue index (16.5 +/- 1.8 vs 16.6 +/- 1.8 W.s-1). Peak heart rate (181.6 +/- 3.7 vs 181.4 +/- 3.8 bpm), or blood lactate (14.0 +/- 0.9 vs 13.8 +/- 0.8 mmol.l-1) 3 min after the exercise bout were not significantly different between treatments.(ABSTRACT TRUNCATED AT 250 WORDS)

The acute effects of inhaled albuterol, a selective beta-2 adrenergic agonist, on measures of endurance cycling performance and pulmonary function were assessed in 21 competitive road cyclists. A 5 step methacholine challenge revealed all cyclists to be non-asthmatic. Albuterol (A) total dose 360 micrograms or a saline placebo (P) was administered by inhaler, in 4 metered doses of 90 micrograms each, 15 minutes before cycle ergometry exercise. Heart rate, whole blood lactate, perceived exertion and VO2 were determined at the submaximal workloads of 150, 200, 225, 250, 275, 300 watts and at max. Pulmonary function tests determining forced vital capacity, forced expiratory volume during the first second of expiration, forced mid-expiratory flow and maximal voluntary ventilation were performed prior to and 10 minutes after inhalation; and 5, 10 and 15 minutes after termination of the exercise protocol. Heart rate was significantly greater during the A compared to the P treatment at 200 (150.8 +/- 2.5 vs 146.7 +/- 2.8 beats per minute), 225 (159.7 +/- 2.4 vs 154.6 +/- 2.7 beats per minute) and 250 watts (166.9 +/- 2.4 vs 164.4 +/- 2.6 beats per minute). Whole blood lactate was significantly greater during the A compared to the P treatment at 275 watts (4.7 +/- 0.3 vs 4.2 +/- 0.4 mmol.l-1). No other significant differences were found between the 2 treatments at any time point. These data indicate that the acute effect of albuterol inhalation at twice the recommended dosage has no positive effect on endurance performance measures or pulmonary function in athletes who are not asthmatic.

The effects of short-term overwork on performance measures, blood lactate, and plasma ammonia concentrations were examined in 28 elite junior weightlifters who participated in a 2 wk high volume resistance training camp. Performance testing (maximum effort vertical jump test and snatch lift) and blood chemistry analyses (ammonia and lactate) were conducted before (T1) and after (T2) 7 d of high volume training (2-3 workouts/d). Blood samples were collected from an antecubital vein at rest, preexercise, 5 min postexercise, and 15 min postexercise at T1 and T2. Results indicated a significant decrease from T1 to T2 in the maximum effort vertical jump test while the snatch lift test yielded no difference across time. Blood lactate and ammonia concentrations were significantly lower at 5 min postexercise at T2 while resting ammonia concentrations were significantly elevated at T2 compared to corresponding measures at T1. These data suggest possible early symptoms of overwork at T2 (decrease in performance of the maximum effort vertical jump test and the elevated resting ammonia concentrations); however, lower 5 min postexercise concentrations of lactate and ammonia at T2 indicated a positive adaptation to the 1 wk high volume resistance training period.

Cardiac magnetic resonance imaging was performed on 14 junior elite Olympic weight lifters and 14 controls (means +/- Se, age = 18.4 +/- 0.5 and 17.8 +/- 0.4 years, weight = 76.5 +/- 3.6 and 78.8 +/- 3.3 kg, % fat = 6.5% +/- 0.8% and 11.5% +/- 1.7%, respectively). Controls were individually matched to the lifters to within 2 years of age and 2.5 kg of body weight. Systolic (S) and diastolic (D) left posterior wall thickness (LPW), left ventricular short axis (LSA), left ventricular transverse long axis (LLA), spetal wall thickness (SW), right ventricular wall thickness (RWT), and right ventricular short axis (RSA) were determined. Variables were examined in absolute (mm), relative to body surface area (BSA, mm/m2), total body weight (BW, mm/kg), and lean body mass (LBM, mm/kg) terms. In absolute terms S LPW (21.1 +/- 1.7 vs 13.3 +/- 0.5 mm), S SW (15.3 +/- 1.3 vs 11.7 +/- 0.6 mm), and D LLA (75.2 +/- 1.6 vs 69.1 +/- 2.4 mm) were significantly greater and S LSA (23.4 +/- 2.4 vs 36.7 +/- 2.3 mm) and S LLA (46.5 +/- 3.7 vs 58.2 +/- 3.8 mm) were significantly less in the lifters vs the controls. S LPW/BW, S LPW/BSA, S LPW/LBM, S SW/BW, S SW/BSA, S SW/LBM, D LSA/BSA, and D LLA/BSA were significantly greater and S LSA/BW, B LSA/BSA, S LSA/LBM, S LLA/BSA, S LLA/LBM, and D SW/LBM were significantly less in the lifters than the controls.(ABSTRACT TRUNCATED AT 250 WORDS)